Opportunity

SAM #PANDHA26P0000034421

Sole Source Procurement of Roche Cobas Liat PCR System, Test Kits, and Maintenance for Shaw Air Force Base

Buyer

Defense Health Agency

Posted

June 05, 2026

Respond By

June 19, 2026

Identifier

PANDHA26P0000034421

NAICS

423450, 532283, 621511, 334516, 325413

This opportunity is a sole-source procurement by the Defense Health Agency Contracting Activity Healthcare Contracting Division, Southeast (DHACA-HCD-SE) for molecular diagnostic equipment and services at Shaw Air Force Base, South Carolina. - Sole-source contract to Roche Diagnostics for Cobas Liat PCR System - Includes: - One Cobas Liat Assays Analyzer - PCR test kits for SARS-Cov-2, Influenza A/B, RSV, and Streptococcus A - Control kits for each test type - Cleaning tool kit - Comprehensive maintenance and support services - On-site personnel training and start-up studies - Estimated annual test volume: 3,300-3,800 tests - Justified under FAR 6.302-1 due to proprietary technology and unique capabilities - Period of performance: Base year (Sept 1, 2026 - Aug 31, 2027) plus four one-year options (through Aug 31, 2031) - No other vendors or products will be considered; Roche Diagnostics is the only OEM specified - Commercial competitors could include Abbott, Cepheid, and Thermo Fisher for similar PCR systems - Key requirements: rapid molecular real-time PCR testing, comprehensive maintenance, and training - All products and services are to be delivered and performed at Shaw Air Force Base, SC

Description

NOTICE OF INTENT TO SOLE SOURCE:

This Notice of Intent is not a request for competitive proposals. This is not a solicitation or request for offers. No solicitation package is available, and telephone requests will not be honored. Only one responsible source, and no other supplies or services will satisfy agency requirements.

The Defense Health Agency Contracting Activity Healthcare Contracting Division, Southeast (DHACA-HCD-SE) provides notice of its intent to award a firm-fixed-price, sole-source contract to Roche Diagnostics. This notice is not a request for competitive proposals; no solicitation package is available, and telephone requests will not be honored. The acquisition is conducted under the authority of Federal Acquisition Regulation (FAR) 6.302-1, "Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements."

Reference the attached Notice of Intent (NOI)

View original listing